Dr. Peter Block interviews presenter Dr. Eri Toda Kato regarding dapagliflozin on HF and mortality in diabetes based on EF (DECLARE TIMI-58).

Clinical Topics: Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Prevention, Acute Heart Failure

Keywords: ACC Annual Scientific Session, ACC19, Diabetes Mellitus, Type 2, Stroke Volume, Heart Failure, Benzhydryl Compounds, Primary Prevention, Metabolic Syndrome

< Back to Listings